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CD4+ proINS 76-90 (SLQPLALEGSLQKRG) specific T cells using
soluble fluorescent MHC class II tetramers. Subjects with type
1 diabetes (T1D; n=10) and healthy controls (n=8) with high
levels of peripheral proINS -specific T cells were charac-
terized by the presence of a “disease-susceptible” polymor-
phism in the INS-VNTR gene. Conversely, subjects with a
“protective” polymorphism in the INS-VNTR gene had nearly
undetectable levels of proINS tetramer-positive T cells. Using
tetramers to isolate proINS -specific T cells from subjects
with both INS-VNTR genotypes, transcript arrays (Affimetrix)
followed by quantitative Q-PCR profiling have identified
several induced pro-apoptotic genes (FASLG, TNF, TNFSF11),
and cytokine (IL-2, IFNg, IL-22, IL1B, IL-10, IL-7) and
chemokine (CCL22) pathways in controls, but not diabetic
subjects, likely representing a second peripheral mechanism
for maintenance of tolerance to self antigens. These results
strongly imply a direct relationship between genetic control
of autoantigen expression and peripheral autoreactivity, in
which proINS genotype restricts the quantity and quality of
the potential T cell response.
doi:10.1016/j.clim.2010.03.026
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Siobhan Ni Choileain1, Nathan Weyand2, Magdalene So2,
Belinda Weller1, Anne Astier1. 1University of Edinburgh,
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The regulator of complement activity CD46 acts as a
costimulatory molecule for T cells and promotes their
differentiation into Tr1 cells, secreting notably the anti-
inflammatory cytokine IL-10. We previously demonstrated
that CD46 pathway is dysregulated in T cells frompatients with
multiple sclerosis (MS), as IL-10 secretion is impaired. Herein,
we have followed CD46 expression upon T cell activation in
cells from a cohort of healthy donors and patients in the RRMS
stage. Upon CD46 activation, we first observed the cleavage of
its ectodomains by MMPs, which is regulated by the TCR. By
homology to Notch, this generates a C-terminal fragment
(CTF) that can be further cleaved by the gamma-secretase
enzymatic complex. Indeed, loss of expression of both
cytoplasmic isoforms occurred after activation, which could
be partly restored by addition of a gamma-secretase inhibitor.
We did not observe a defect in cleavage of CD46 ectodomain
in T cells from patients with MS. However, the loss of CD46
cytoplasmic tails was not observed in T cells from patients.
CD46 processing was required for its functions, as demonstrat-
ed by the following results: i) addition of gamma-secretase
inhibitors to T cell culture inhibited IL-10 production by CD46-
activated T cells; ii) expression of a pre-cleaved CTF-cyt1
fragment of CD46 resulted into increased IL-10 production;
iii) our preliminary data suggest that both tails are found in the
nucleus of activated T cells. Altogether, this suggests that an
altered CD46 processing might be at least partly responsible
for its defective role in MS.
doi:10.1016/j.clim.2010.03.027
OR.11. Citrullinated Fibrinogen Stimulates TNF
Release via TLR4 and Citrullinated Fibrinogen
Immune Complexes Co-stimulate through TLR4 and
the Fc Gamma Receptor
Jeremy Sokolove, Xiayan Zhao, William Robinson. Stanford
University, Palo Alto, CA
Extravasation of fibrin(ogen) is a characteristic pathologic
finding within the RA synovium. Citrullinated proteins have
been demonstrated at many sites of inflammation and
citrullinated fibrin(ogen) has been consistently identified
within the RA synovium. The presence of anti-citrulline
protein antibodies characterizes RA and has been associated
with increased RA severity. The innate immune receptor
TLR4 is critical in murine models of RA and has been
implicated in human RA. Several studies have demonstrated
TLR4 dependent signaling by non-microbial damage associ-
ated molecules including fibrin(ogen). In this study we
demonstrate a dose dependent ability of native and cFb to
stimulate macrophage TNF secretion and confirm that this
process is TLR4 (and MyD88) dependent. Notably, cFb
displayed approximately ten-fold increased potency over
native fibrinogen. In-vitro generated cFb containing IC
stimulated TNF release at levels significantly above that
seen with cFb alone via a process dependent on the
combination of TLR4 and the Fc gamma receptor. This
study demonstrates that citrullination of fibrinogen dramat-
ically increases it's potency on TLR4 mediated TNF release
and that cFb IC can co-stimulate through TLR4 and the Fc
gamma receptor. Given that citrullination is ubiquitous to
sites of inflammation, the ability to increase the potency of
an innate damage associated molecule via citrullination is
highly novel with potentially broad generalization to the
field of innate immunity. Additionally, the ability of cFb
containing IC to co-stimulate TNF release provides a
potential pathogenic mechanism for RA associated auto-
antibodies in the initiation and propagation of synovial
inflammation.
doi:10.1016/j.clim.2010.03.028
OR.12. Blockade of CD94/NKG2A Prevents EAE
Jianmei Leavenworth2, Carola Schellack Wenander1,
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NK cells are important members of the innate immune
system that have been implicated in anti-microbial and anti-
tumor defense as well as in maintenance of tolerance and
control of autoimmune diseases. The activity of NK cells is
regulated by a delicate balance of both activating and
inhibitory receptors. CD94/NKG2A is an inhibitory receptor
expressed in mice mainly on NK and a subset of CD8+ T cells
recognizing the non-classical class I molecule Qa-1. Target-
ing CD94/NKG2A receptor by blocking its interaction
with Qa-1 by a monoclonal antibody is a new therapeutic
approach to increase NK cell activity in the treatment of
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